Thymic Output and CD4 T-Cell Reconstitution in HIV-Infected Children on Early and Interrupted Antiretroviral Treatment: Evidence from the Children with HIV Early Antiretroviral Therapy Trial

Thymic Output and CD4 T-Cell Reconstitution in HIV-Infected Children on Early and Interrupted Antiretroviral Treatment: Evidence from the Children with HIV Early Antiretroviral Therapy Trial

<h4>Objectives</h4> <p>Early treatment of HIV-infected children and adults is important for optimal immune reconstitution. Infants’ immune systems are more plastic and dynamic than older children’s or adults’, and deserve particular attention. This study aimed to understand the re...

Detaylı Bibliyografya
Asıl Yazarlar:	Lewis, J, Payne, H, Walker, A, Otwombe, K, Gibb, D, Babiker, A, Panchia, R, Cotton, M, Violari, A, Klein, N, Callard, R
Materyal Türü:	Journal article
Baskı/Yayın Bilgisi:	Frontiers Media 2017

Benzer Materyaller

Prevalence and Risk Factors for Hepatic Steatosis in Children With Perinatal HIV on Early Antiretroviral Therapy Compared to HIV-Exposed Uninfected and HIV-Unexposed Children
Yazar:: Penelope C. Rose, ve diğerleri
Baskı/Yayın Bilgisi: (2022-06-01)

Age and CD4 count at initiation of antiretroviral therapy in HIV-infected children: effects on long-term T-cell reconstitution.
Yazar:: Lewis, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Early severe HIV disease precedes early antiretroviral therapy in infants: Are we too late?
Yazar:: Steve Innes, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)

Relationship between changes in thymic emigrants and cell-associated HIV-1 DNA in HIV-1-infected children initiating antiretroviral therapy.
Yazar:: De Rossi, A, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Cortical structural changes related to early antiretroviral therapy (ART) interruption in perinatally HIV-infected children at 5 years of age
Yazar:: Emmanuel C. Nwosu, ve diğerleri
Baskı/Yayın Bilgisi: (2021-06-01)

Early ART-initiation and longer ART duration reduces HIV-1 proviral DNA levels in children from the CHER trial
Yazar:: Helen Payne, ve diğerleri
Baskı/Yayın Bilgisi: (2021-09-01)

When to start antiretroviral therapy in infants and children
Yazar:: Mark F Cotton, ve diğerleri
Baskı/Yayın Bilgisi: (2009-12-01)

When should children with HIV infection be started on antiretroviral therapy?
Yazar:: Steven B Welch, ve diğerleri
Baskı/Yayın Bilgisi: (2008-03-01)

Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study.
Yazar:: Picat, M, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation
Yazar:: Avy Violari, ve diğerleri
Baskı/Yayın Bilgisi: (2019-01-01)

6 Epigenetic dysregulation of the major histocompatibility complex (MHC) region in HIV-infected children on early antiretroviral therapy
Yazar:: Stephanie Shiau, ve diğerleri
Baskı/Yayın Bilgisi: (2017-07-01)

Antiretroviral therapy interruptions: impact on HIV treatment and transmission
Yazar:: Dubrocq G, ve diğerleri
Baskı/Yayın Bilgisi: (2018-06-01)

Different profiles of immune reconstitution in children and adults with HIV-infection after highly active antiretroviral therapy
Yazar:: Leal Manuel, ve diğerleri
Baskı/Yayın Bilgisi: (2006-07-01)

Virological remission after antiretroviral therapy interruption in female African HIV seroconverters
Yazar:: Gossez, M, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Biphasic decay of cell-associated HIV-1 DNA in HIV-1-infected children on antiretroviral therapy.
Yazar:: De Rossi, A, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

The Benefits of Early Antiretroviral Therapy for HIV Infection: How Early is Early Enough?
Yazar:: Sulggi A. Lee, ve diğerleri
Baskı/Yayın Bilgisi: (2016-09-01)

Cases inefficient antiretroviral therapy for HIV-1 in children
Yazar:: Yu. V. Ostankova, ve diğerleri
Baskı/Yayın Bilgisi: (2017-06-01)

Pubertal development in HIV-infected African children on first-line antiretroviral therapy.
Yazar:: Szubert, A, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Monitoring of highly active antiretroviral therapy in HIV infection.
Yazar:: Walker, A, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Cardiac Effects of Antiretroviral-Naïve versus Antiretroviral-Exposed HIV Infection in Children.
Yazar:: Nikmah S Idris, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)

Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerations
Yazar:: Samual A. Garner, ve diğerleri
Baskı/Yayın Bilgisi: (2017-04-01)

IMPROVING ANTIRETROVIRAL THERAPY IN CHILDREN WITH HIV INFECTION
Yazar:: V. B. Denisenko, ve diğerleri
Baskı/Yayın Bilgisi: (2018-07-01)

Antiretroviral therapy during pregnancy and early neonatal life: consequences for HIV-exposed, uninfected children
Yazar:: Patrícia El Beitune, ve diğerleri

Interruptions of antiretroviral therapy in children and adolescents with HIV infection in clinical practice: a retrospective cohort study in the USA
Yazar:: Natella Rakhmanina, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)

Understanding early HIV-1 rebound dynamics following antiretroviral therapy interruption: The importance of effector cell expansion.
Yazar:: Tin Phan, ve diğerleri
Baskı/Yayın Bilgisi: (2024-07-01)

Correction: Association of Diversity with Antiretroviral Treatment Outcomes among HIV-Infected African Children.
Yazar:: Iris Chen, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Preventing antiretroviral treatment interruptions among HIV/AIDS patients in Africa.
Yazar:: Edward J Mills, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Unwillingness of patients in Ghana to interrupt antiretroviral therapy for HIV cure research
Yazar:: Evelyn Y. Bonney, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

Pharmacokinetics of antiretroviral drug varies with formulation in the target population of children with HIV-1.
Yazar:: Kasirye, P, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Antiretroviral choice and severe disease predict poorer neuropsychological outcomes in HIV+ children from Africa
Yazar:: Lee Fairlie, ve diğerleri
Baskı/Yayın Bilgisi: (2022-08-01)

Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects
Yazar:: Haberer, J, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Drug monitoring of antiretroviral drugs in children with perinatal HIV infection
Yazar:: A. Yu. Sambyalova, ve diğerleri
Baskı/Yayın Bilgisi: (2024-07-01)

Early antiretroviral therapy reduces hiv dna following perinatal HIV infection
Yazar:: Foster, C, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trial.
Yazar:: Musiime, V, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

When to start antiretroviral therapy in HIV-infected children
Yazar:: Tammy Meyers
Baskı/Yayın Bilgisi: (2002-07-01)

Hepatotoxicity in HIV-infected children and adolescents on antiretroviral therapy
Yazar:: Ana Cecília Montes Gil, ve diğerleri

Adherence and effectiveness of antiretroviral therapy in HIV infected children
Yazar:: K S Sanjay, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)

Evolution of antiretroviral phenotypic and genotypic drug resistance in antiretroviral-naive HIV-1-infected children treated with abacavir/lamivudine, zidovudine/lamivudine or abacavir/zidovudine, with or without nelfinavir (the PENTA 5 trial).
Yazar:: Gibb, D, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Early Colorectal Responses to HIV-1 and Modulation by Antiretroviral Drugs
Yazar:: Carolina Herrera, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

Increased thymic output after initiation of antiretroviral therapy in human immunodeficiency virus type 1-infected children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 Trial.
Yazar:: De Rossi, A, ve diğerleri
Baskı/Yayın Bilgisi: (2002)